Pops Richard F has filed 25 Form 4s with the SEC that we hold, for Neurocrine Biosciences INC (NBIX) (Director) and Alkermes plc. (ALKS) (Director and CEO, Alkermes plc, Director). Across all of them we count 0 purchases worth $0 and 12 sales worth $20.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($2.4M). The largest single trade was a sale of 221,222 shares of Alkermes plc. worth $6.2M, dated 2022-05-05. The first filing on our record is dated 2021-09-16 and the latest 2026-05-29.
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-09 | S, sale reported on Form 4 | 7,500 | $572.2K | 2022-05-11 |
| 2022-05-09 | S, sale reported on Form 4 | 7,500 | $572.2K | 2022-05-11 |
| 2023-01-03 | S, sale reported on Form 4 | 15,000 | $1.8M | 2023-01-05 |
| 2024-02-20 | S, sale reported on Form 4 | 15,000 | $2.0M | 2024-02-22 |
| 2024-03-08 | S, sale reported on Form 4 | 1,700 | $238.1K | 2024-03-12 |
| 2024-03-11 | S, sale reported on Form 4 | 100 | $14.0K | 2024-03-12 |
| 2024-03-13 | S, sale reported on Form 4 | 23,200 | $3.3M | 2024-03-15 |
| 2024-05-17 | S, sale reported on Form 4 | 2,100 | $297.9K | 2024-05-21 |
| 2026-05-15 | S, sale reported on Form 4 | 15,000 | $2.4M | 2026-05-18 |
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-05 | S, sale reported on Form 4 | 32,288 | $923.1K | 2022-05-06 |
| 2022-05-05 | S, sale reported on Form 4 | 221,222 | $6.2M | 2022-05-06 |
| 2022-05-06 | S, sale reported on Form 4 | 93,747 | $2.6M | 2022-05-06 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1126490) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms
No password to create and no card required. We store your email address and nothing else.